| [1] |
Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin[J]. J Cataract Refract Surg, 2005, 31(4): 664－673.
|
| [2] |
Bell CM, Hatch WV, Fischer HD, et al. Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery[J]. JAMA, 2009, 301(19): 1991－1996.
|
| [3] |
Arshinoff SA. Modified SST－USST for tamsulosin－associated intraocular floppy－iris syndrome[J]. J Cataract Refract Surg, 2006, 32(4): 559－561.
|
| [4] |
Ozcura F, Irgat SG. Bilateral Intraoperative Floppy Iris Syndrome Associated with Silodosin Intake[J]. Eurasian J Med, 2020, 52(1): 100－102.
|
| [5] |
Yang X, Liu Z, Fan Z, et al. A narrative review of intraoperative floppy iris syndrome: an update 2020[J]. Ann Transl Med, 2020, 8(22): 1546.
|
| [6] |
Alio JL. Cataract Surgery: From Today′s Standards to Future Progress[J]. Asia Pac J Ophthalmol (Phila), 2017, 6(4): 309.
|
| [7] |
Schwinn DA, Afshari NA. α1－Adrenergic Receptor Antagonists and the Iris: New Mechanistic Insights into Floppy Iris Syndrome[J]. Survey of Ophthalmology, 2006, 51(5): 501－512.
|
| [8] |
姚克. 关注白内障手术中的虹膜松弛综合征[J]. 中华眼科杂志，2012, 48(4): 289－291.
|
| [9] |
Friedman, Alan H. Tamsulosin and the Intraoperative Floppy Iris Syndrome[J]. Jama, 2009, 301(19): 2044－2045.
|
| [10] |
Wahl M, Tipotsch－Maca SM, Vecsei－Marlovits PV. Intraoperative floppy iris syndrome and its association with various concurrent medications, bulbus length, patient age and gender[J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(1): 113－118.
|
| [11] |
Lim DH, Lee MG, Chung TY, et al. Korean patients taking alpha1－adrenergic receptor antagonists show lower incidence of intraoperative floppy iris syndrome than western patients[J]. Br J Ophthalmol, 2014, 98(4): 479－483.
|
| [12] |
俞捷心，姚克. 白内障超声乳化术中虹膜松弛综合征发生的新危险因素和预测指标[J]. 国际眼科杂志，2017, 17(11): 2126－2129.
|
| [13] |
Wilson MJ, Trivedi RH, Mistr S. Pediatric intraoperative floppy－iris syndrome[J]. J Cataract Refract Surg, 2007, 33(7): 1325－1327.
|
| [14] |
Chatziralli IP, Peponis V, Parikakis E, et al. Risk factors for intraoperative floppy iris syndrome: a prospective study[J]. Eye (Lond), 2016, 30(8): 1039－1044.
|
| [15] |
Issa SA, Dagres E. Intraoperative floppy－iris syndrome and finasteride intake[J]. J Cataract Refract Surg, 2007, 33(12): 2142－2143.
|
| [16] |
Kaczmarek IA, Prost ME, Wasyluk J. Clinical risk factors associated with intraoperative floppy iris syndrome: a prospective study[J]. Int Ophthalmol, 2019, 39(3): 541－549.
|
| [17] |
Tzamalis A, Malyugin B, Ziakas N, et al. Angiotensin receptor inhibitors as main predisposing factor for intraoperative floppy iris syndrome in women[J]. J Cataract Refract Surg, 2019, 45(5): 696－697.
|
| [18] |
Tzamalis A, Matsou A, Dermenoudi M, et al. The role of sex in intraoperative floppy－iris syndrome[J]. J Cataract Refract Surg, 2019, 45(1): 41－47.
|
| [19] |
Chen AA, Kelly JP, Bhandari A, et al. Pharmacologic prophylaxis and risk factors for intraoperative floppy－iris syndrome in phacoemulsification performed by resident physicians[J]. J Cataract Refract Surg, 2010, 36(6): 898－905.
|
| [20] |
Christou CD, Tsinopoulos I, Ziakas N, et al. Intraoperative Floppy Iris Syndrome: Updated Perspectives[J]. Clin Ophthalmol, 2020, 14：463－471.
|
| [21] |
Perumal C, Chowdhury PS, Ananthakrishnan N, et al. A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement[J]. Urol Ann, 2015, 7(1): 74－78.
|
| [22] |
Schwinn DA, Roehrborn CG. Alpha1－adrenoceptor subtypes and lower urinary tract symptoms[J]. Int J Urol, 2008, 15(3): 193－199.
|
| [23] |
Keklikci U, Isen K, Unlu K, et al. Incidence, clinical findings and management of intraoperative floppy iris syndrome associated with tamsulosin[J]. Acta Ophthalmol, 2009, 87(3): 306－309.
|
| [24] |
Lunacek A, Mohamad AB, Radmayr C, et al. Ten years of intraoperative floppy iris syndrome in the era of alpha－blockers[J]. Cent European J Urol, 2018, 71(1): 98－104.
|
| [25] |
Goseki T, Ishikawa H, Ogasawara S, et al. Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: Possible mechanism of intraoperative floppy－iris syndrome[J]. J Cataract Refract Surg, 2012, 38(9): 1643－1649.
|
| [26] |
Zaman F, Bach C, Junaid I, et al. The floppy iris syndrome － what urologists and ophthalmologists need to know[J]. Curr Urol, 2012, 6(1): 1－7.
|
| [27] |
Nuzzi R, Arnoffi P, Tridico F. Best Prophylactic Strategy in Groups at Risk of Intraoperative Floppy Iris Syndrome Development: Comparison Between Atropine Instillation and Adrenaline Intracameral Injection[J]. Open Ophthalmol J, 2018, 12：34－40.
|
| [28] |
Aktas Z, Yuksel N, Ceylan G, et al. The effects of tamsulosin and alfuzosin on iris morphology: an ultrasound biomicroscopic comparison[J]. Cutan Ocul Toxicol, 2015, 34(1): 38－41.
|
| [29] |
Chang DF, Campbell JR, Colin J, et al. Prospective Masked Comparison of Intraoperative Floppy Iris Syndrome Severity with Tamsulosin versus Alfuzosin[J]. Ophthalmology, 2014, 121(4): 829－834.
|
| [30] |
Dogan M, Kutluksaman B, Keles I, et al. The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia[J]. Curr Eye Res, 2017, 42(12): 1638－1643.
|
| [31] |
Chatterjee S, Agrawal D. Silodosin－associated intraoperative floppy iris syndrome[J]. Indian J Ophthalmol, 2017, 65(6): 538－539.
|
| [32] |
Ozcura F, Irgat SG. Bilateral Intraoperative Floppy Iris Syndrome Associated with Silodosin Intake[J]. Eurasian J Med, 2020, 52(1): 100－102.
|
| [33] |
Wong AC, Mak ST. Finasteride－associated cataract and intraoperative floppy－iris syndrome[J]. J Cataract Refract Surg, 2011, 37(7): 1351－1354.
|
| [34] |
Pringle E, Packard R. Antipsychotic agent as an etiologic agent of IFIS[J]. J Cataract Refract Surg, 2005, 31(12): 2240－2241.
|
| [35] |
Unal M, Yucel I, Tenlik A. Intraoperative floppy－iris syndrome associated with chronic use of chlorpromazine[J]. Eye (Lond), 2007, 21(9): 1241－1242.
|
| [36] |
Matsuo M, Sano I, Ikeda Y, et al. Intraoperative floppy－iris syndrome associated with use of antipsychotic drugs[J]. Canadian Journal of Ophthalmology, 2016, 51(4): 294－296.
|
| [37] |
Gonzalez－Martin－Moro J, Gonzalez－Lopez JJ, Zarallo－Gallardo J, et al. Intraoperative floppy iris syndrome after treatment with duloxetine: coincidence, association, or causality？[J]. Arch Soc Esp Oftalmol, 2015, 90(2): 94－96.
|
| [38] |
Papadopoulos R, Bachariou A. Intraoperative floppy－iris syndrome associated with chronic intake of donepezil[J]. J Cataract Refract Surg, 2007, 33(11): 1997－1998.
|
| [39] |
Neff KD, Sandoval HP, Fernández De Castro LE, et al. Factors Associated with Intraoperative Floppy Iris Syndrome[J]. Ophthalmology, 2009, 116(4): 658－663.
|
| [40] |
Enright JM, Karacal H, Tsai LM. Floppy iris syndrome and cataract surgery[J]. Curr Opin Ophthalmol, 2017, 28(1): 29－34.
|
| [41] |
Altan－Yaycioglu R, Gedik S, Pelit A, et al. Clinical factors associated with floppy iris signs: a prospective study from two centers[J]. Ophthalmic Surg Lasers Imaging, 2009, 40(3): 232－238.
|
| [42] |
Casuccio A, Cillino G, Pavone C, et al. Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy－iris syndrome[J]. J Cataract Refract Surg, 2011, 37(8): 1447－1454.
|
| [43] |
Terauchi Y, Horiguchi H, Shiba T. The Pharmacological Mydriatic Pupil－to－Limbal Diameter Ratio as an Intuitive Predictor for the Risk of Intraoperative Floppy Iris Syndrome[J]. J Ophthalmol, 2018: 2837934.
|
| [44] |
Esen F, Bulut AE, Toker E. Efficacy and safety of low－concentration, bisulphite－containing, intracameral epinephrine and topical atropine treatments for the prevention of intraoperative floppy iris syndrome[J]. Cutan Ocul Toxicol, 2018, 37(3): 286－290.
|
| [45] |
Nuzzi R, Arnoffi P, Tridico F. Best Prophylactic Strategy in Groups at Risk of Intraoperative Floppy Iris Syndrome Development: Comparison Between Atropine Instillation and Adrenaline Intracameral Injection[J]. Open Ophthalmol J, 2018, 12：34－40.
|
| [46] |
Bendel RE, Phillips MB. Preoperative use of atropine to prevent intraoperative floppy－iris syndrome in patients taking tamsulosin[J]. J Cataract Refract Surg, 2006, 32(10): 1603－1605.
|
| [47] |
Visco D. Effect of phenylephrine/ketorolac on iris fixation ring use and surgical times in patients at risk of intraoperative miosis[J]. Clin Ophthalmol, 2018, 12：301－305.
|
| [48] |
Lunacek A, Mohamad AB, Radmayr C, et al. Ten years of intraoperative floppy iris syndrome in the era of alpha－blockers[J]. Cent European J Urol, 2018, 71(1): 98－104.
|
| [49] |
Moore SP, Goggin M. Intraoperative floppy iris syndrome and microincision cataract surgery[J]. J Cataract Refract Surg, 2010, 36(11): 2008.
|
| [50] |
叶宏权，韩宇，汤静，等. 同轴微切口白内障超声乳化术控制术中虹膜松弛综合征的疗效分析[J]. 眼科新进展，2017，37(5)：462－465.
|
| [51] |
Blau－Most M, Mimouni M, Geffen N, et al. Modified Corneal Incisions for Cataract Surgery in Patients Treated with Tamsulosin: A Prospective Study[J]. Curr Eye Res, 2019, 44(4): 381－384.
|
| [52] |
Armarnik S, Mimouni M, Rosen E, et al. Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)－prone patients[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(1): 123－127.
|
| [53] |
Nguyen DQ, Sebastian RT, Kyle G. Surgeon's experiences of the intraoperative floppy iris syndrome in the United Kingdom[J]. Eye (Lond), 2007, 21(3): 443－444.
|
| [54] |
Mylona I, Dermenoudi M, Ziakas N, et al. Increased pupil diameter is a protective factor against intraoperative floppy iris syndrome[J]. Clinical and Experimental Optometry, 2019, 103(5): 704－705.
|
| [55] |
Lorente R, de Rojas V, Vazquez DPP, et al. Intracameral phenylephrine 1.5% for prophylaxis against intraoperative floppy iris syndrome: prospective, randomized fellow eye study[J]. Ophthalmology, 2012, 119(10): 2053－2058.
|
| [56] |
Guthrie S, Jensen T, Hartley RC, et al. Assessing the accuracy of intracameral phenylephrine preparation in cataract surgery[J]. Eye (Lond), 2018, 32(10): 1615－1620.
|
| [57] |
Silverstein SM, Rana VK, Stephens R, et al. Effect of phenylephrine 1.0%－ketorolac 0.3% injection on tamsulosin－associated intraoperative floppy－iris syndrome[J]. J Cataract Refract Surg, 2018, 44(9): 1103－1108.
|
| [58] |
Donnenfeld ED, Whitaker JS, Jackson MA, et al. Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery[J]. J Cataract Refract Surg, 2017, 43(5): 597－605.
|
| [59] |
Grzybowski A, Kanclerz P. Methods for achieving adequate pupil size in cataract surgery[J]. Curr Opin Ophthalmol, 2020, 31(1): 33－42.
|
| [60] |
Nderitu P, Ursell P. Iris hooks versus a pupil expansion ring: Operating times, complications, and visual acuity outcomes in small pupil cases[J]. J Cataract Refract Surg, 2019, 45(2): 167－173.
|
| [61] |
Chang DF. Use of Malyugin pupil expansion device for intraoperative floppy－iris syndrome: results in 30 consecutive cases[J]. J Cataract Refract Surg, 2008, 34(5): 835－841.
|
| [62] |
Tan R, Wang X, Perera SA, et al. Numerical stress analysis of the iris tissue induced by pupil expansion: Comparison of commercial devices[J]. PLoS One, 2018, 13(3): e194141.
|
| [63] |
Lockington D, Wang Z, Qi N, et al. Modelling floppy iris syndrome and the impact of pupil size and ring devices on iris displacement[J]. Eye (Lond), 2020, 12(34): 2227－2234.
|